AI and Drug Discovery, Protecting the Value of Data in Collaborations

JEFFREY KANG | September 23, 2019

article image
AI and Pharma update, Melloddy project—a ground-breaking collaboration between pharmaceutical companies, technology companies, and academic institutions to accelerate drug discovery by sharing pharmaceutical industry data. As we explained, the Melloddy project uses federated learning and blockchain technology to train machine learning (ML) engines using a decentralized architecture that protects each partner’s proprietary data. The Melloddy project is part of a growing trend of using AI/ML in the pharmaceutical industry, which we investigated in Part 1 of our update. In this some of the legal issues surrounding the use of AI/ML in collaborative drug discovery and some solutions for addressing these issues.

Spotlight

Pharma Partners

Autorizzata da AIFA al confezionamento secondario di farmaci, l'Azienda è anche certificata ISO 13485 per il confezionamento secondario di medical devices e prodotti diagnostici. L'Azienda offre ai propri clienti un servizio con standard elevati di qualità, nel rispetto dei tempi di consegna ed a prezzi competitivi. La definizione delle Responsabilità avviene tramite la stipula di Quality Agreements con i clienti prima dell'inizio di una nuova lavorazione. L'Azienda esegue confezionamenti secondari, riconfezionamenti, sostituzione di componenti, etichettatura, allestimento espositori, allestimento kit diagnostici multicomponente. L'Azienda, pur di recente fondazione, è riuscita a consolidare rapporti stabili con clienti farmaceutici e diagnostici di rilevanza nazionale ed internazionale.

OTHER ARTICLES

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | April 3, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Spotlight

Pharma Partners

Autorizzata da AIFA al confezionamento secondario di farmaci, l'Azienda è anche certificata ISO 13485 per il confezionamento secondario di medical devices e prodotti diagnostici. L'Azienda offre ai propri clienti un servizio con standard elevati di qualità, nel rispetto dei tempi di consegna ed a prezzi competitivi. La definizione delle Responsabilità avviene tramite la stipula di Quality Agreements con i clienti prima dell'inizio di una nuova lavorazione. L'Azienda esegue confezionamenti secondari, riconfezionamenti, sostituzione di componenti, etichettatura, allestimento espositori, allestimento kit diagnostici multicomponente. L'Azienda, pur di recente fondazione, è riuscita a consolidare rapporti stabili con clienti farmaceutici e diagnostici di rilevanza nazionale ed internazionale.

Events